Dexmedetomidine as a Part of General Anesthesia for Cesarean Delivery in Patients with Pre-eclampsia: Efficacy and Fetal Outcome

Dexmedetomidine adminstration in Patients with Pre-eclampsia undergoing caeserian section

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR201706002303170

Enrollment

Registered

2017-05-19

Start date

2016-08-06

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pregnancy and Childbirth Surgery anesthesia Anaesthesia

Interventions

normal saline

dexmedetomidine

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Patients included were 18-40 years, with gestational age ¿ 34 weeks and have mild pre-eclampsia with a systolic blood pressure < 160 mm Hg and a diastolic blood pressure < 110 mmHg and urinary protein dipstick + or 2+.

Exclusion criteria

Exclusion criteria: Exclusion criteria included patient refusal to be included in the study, allergy to dexmedetomidine, body mass index >40kg/m2, systemic diseases (cardiac, pulmonary, hepatic, renal, neurological, neuromuscular, diabetes mellitus, anemia, coagulation disorders, bleeding disorders, seizures), HELLP syndrome, patients receiving anticoagulant or antipsychotic drugs, anti-partum hemorrhage, fetal distress and multiple pregnancy.

Design outcomes

Primary

Measure	Time frame
mean arterial blood pressure	—

Secondary

Measure	Time frame
serum cortisol	—

Countries

Egypt

Contacts

Public Contactabdel rahman ahmed

assistant professor,menoufiya faculty of medicine

ameskandr@yahoo.com00201223312987

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026